Fulcrum Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Fulcrum Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2018 to Q2 2024.
  • Fulcrum Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 200M 0 0% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 200M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 200M 0 0% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 200M 0 0% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 200M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 200M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 200M 0 0% Dec 31, 2022 10-K 2024-02-27
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 200M 0 0% Dec 31, 2021 10-K/A 2023-06-26
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 200M 0 0% Dec 31, 2020 10-K/A 2023-06-26
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 200M +52.5M +35.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 200M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 200M +65M +48.1% Dec 31, 2019 10-K/A 2023-06-23
Q3 2019 200M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 148M Jun 30, 2019 10-Q 2019-08-26
Q4 2018 135M Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.